Cystine/glutamate transporter (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cystine/glutamate transporter" in English language version.

refsWebsite

Global rank English rank

25nih.gov

4^th place

14doi.org

2^nd place

3semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1worldcat.org

5^th place

doi.org

Sato H, Tamba M, Ishii T, Bannai S (April 1999). "Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins". The Journal of Biological Chemistry. 274 (17): 11455–11458. doi:10.1074/jbc.274.17.11455. PMID 10206947.
Wang H, Tamba M, Kimata M, Sakamoto K, Bannai S, Sato H (June 2003). "Expression of the activity of cystine/glutamate exchange transporter, system x(c)(-), by xCT and rBAT". Biochemical and Biophysical Research Communications. 305 (3): 611–618. doi:10.1016/S0006-291X(03)00808-8. PMID 12763038.
Lewerenz J, Maher P, Methner A (January 2012). "Regulation of xCT expression and system x (c) (-) function in neuronal cells". Amino Acids. 42 (1): 171–179. doi:10.1007/s00726-011-0862-x. PMID 21369940. S2CID 12056137.
Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. (February 2013). "The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities". Antioxidants & Redox Signaling. 18 (5): 522–555. doi:10.1089/ars.2011.4391. PMC 3545354. PMID 22667998.
Bridges RJ, Natale NR, Patel SA (January 2012). "System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS". British Journal of Pharmacology. 165 (1): 20–34. doi:10.1111/j.1476-5381.2011.01480.x. PMC 3252963. PMID 21564084.
Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et al. (May 2014). "Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis". eLife. 3: e02523. doi:10.7554/eLife.02523. PMC 4054777. PMID 24844246.
Cao JY, Dixon SJ (June 2016). "Mechanisms of ferroptosis". Cellular and Molecular Life Sciences. 73 (11–12): 2195–2209. doi:10.1007/s00018-016-2194-1. PMC 4887533. PMID 27048822.
Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, et al. (2013-02-10). "The Cystine/Glutamate Antiporter System x c − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities". Antioxidants & Redox Signaling. 18 (5): 522–555. doi:10.1089/ars.2011.4391. ISSN 1523-0864. PMC 3545354. PMID 22667998.
Oliveira KR, Herculano AM, Crespo-López ME, do Nascimento JL (January 2010). "Pharmacological characterization of glutamate Na+-independent transport in retinal cell cultures: implications in the glutathione metabolism". Neurochemistry International. 56 (1): 59–66. doi:10.1016/j.neuint.2009.09.002. PMID 19751785. S2CID 13562289.
Bridges R, Lutgen V, Lobner D, Baker DA (July 2012). "Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling". Pharmacological Reviews. 64 (3): 780–802. doi:10.1124/pr.110.003889. PMC 3400835. PMID 22759795.
Lin CH, Lin PP, Lin CY, Lin CH, Huang CH, Huang YJ, et al. (January 2016). "Decreased mRNA expression for the two subunits of system xc(-), SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia". Journal of Psychiatric Research. 72: 58–63. doi:10.1016/j.jpsychires.2015.10.007. PMID 26540405.
Hardingham GE, Fukunaga Y, Bading H (May 2002). "Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways". Nature Neuroscience. 5 (5): 405–414. doi:10.1038/nn835. PMID 11953750. S2CID 659716.
Bading H (March 2017). "Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations". The Journal of Experimental Medicine. 214 (3): 569–578. doi:10.1084/jem.20161673. PMC 5339681. PMID 28209726.
Jyotsana N, Ta KT, DelGiorno KE (23 February 2022). "The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer". Frontiers in Oncology. 12: 858462. doi:10.3389/fonc.2022.858462. PMC 8904967. PMID 35280777.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000151012 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000027737 – Ensembl, May 2017

nih.gov

pubmed.ncbi.nlm.nih.gov

Sato H, Tamba M, Ishii T, Bannai S (April 1999). "Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins". The Journal of Biological Chemistry. 274 (17): 11455–11458. doi:10.1074/jbc.274.17.11455. PMID 10206947.
Wang H, Tamba M, Kimata M, Sakamoto K, Bannai S, Sato H (June 2003). "Expression of the activity of cystine/glutamate exchange transporter, system x(c)(-), by xCT and rBAT". Biochemical and Biophysical Research Communications. 305 (3): 611–618. doi:10.1016/S0006-291X(03)00808-8. PMID 12763038.
Lewerenz J, Maher P, Methner A (January 2012). "Regulation of xCT expression and system x (c) (-) function in neuronal cells". Amino Acids. 42 (1): 171–179. doi:10.1007/s00726-011-0862-x. PMID 21369940. S2CID 12056137.
Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. (February 2013). "The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities". Antioxidants & Redox Signaling. 18 (5): 522–555. doi:10.1089/ars.2011.4391. PMC 3545354. PMID 22667998.
Bridges RJ, Natale NR, Patel SA (January 2012). "System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS". British Journal of Pharmacology. 165 (1): 20–34. doi:10.1111/j.1476-5381.2011.01480.x. PMC 3252963. PMID 21564084.
Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et al. (May 2014). "Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis". eLife. 3: e02523. doi:10.7554/eLife.02523. PMC 4054777. PMID 24844246.
Cao JY, Dixon SJ (June 2016). "Mechanisms of ferroptosis". Cellular and Molecular Life Sciences. 73 (11–12): 2195–2209. doi:10.1007/s00018-016-2194-1. PMC 4887533. PMID 27048822.
Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, et al. (2013-02-10). "The Cystine/Glutamate Antiporter System x c − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities". Antioxidants & Redox Signaling. 18 (5): 522–555. doi:10.1089/ars.2011.4391. ISSN 1523-0864. PMC 3545354. PMID 22667998.
Oliveira KR, Herculano AM, Crespo-López ME, do Nascimento JL (January 2010). "Pharmacological characterization of glutamate Na+-independent transport in retinal cell cultures: implications in the glutathione metabolism". Neurochemistry International. 56 (1): 59–66. doi:10.1016/j.neuint.2009.09.002. PMID 19751785. S2CID 13562289.
Bridges R, Lutgen V, Lobner D, Baker DA (July 2012). "Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling". Pharmacological Reviews. 64 (3): 780–802. doi:10.1124/pr.110.003889. PMC 3400835. PMID 22759795.
Lin CH, Lin PP, Lin CY, Lin CH, Huang CH, Huang YJ, et al. (January 2016). "Decreased mRNA expression for the two subunits of system xc(-), SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia". Journal of Psychiatric Research. 72: 58–63. doi:10.1016/j.jpsychires.2015.10.007. PMID 26540405.
Hardingham GE, Fukunaga Y, Bading H (May 2002). "Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways". Nature Neuroscience. 5 (5): 405–414. doi:10.1038/nn835. PMID 11953750. S2CID 659716.
Bading H (March 2017). "Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations". The Journal of Experimental Medicine. 214 (3): 569–578. doi:10.1084/jem.20161673. PMC 5339681. PMID 28209726.
Jyotsana N, Ta KT, DelGiorno KE (23 February 2022). "The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer". Frontiers in Oncology. 12: 858462. doi:10.3389/fonc.2022.858462. PMC 8904967. PMID 35280777.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: SLC7A11 solute carrier family 7, (cationic amino acid transporter, y+ system) member 11".
Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. (February 2013). "The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities". Antioxidants & Redox Signaling. 18 (5): 522–555. doi:10.1089/ars.2011.4391. PMC 3545354. PMID 22667998.
Bridges RJ, Natale NR, Patel SA (January 2012). "System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS". British Journal of Pharmacology. 165 (1): 20–34. doi:10.1111/j.1476-5381.2011.01480.x. PMC 3252963. PMID 21564084.
Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et al. (May 2014). "Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis". eLife. 3: e02523. doi:10.7554/eLife.02523. PMC 4054777. PMID 24844246.
Cao JY, Dixon SJ (June 2016). "Mechanisms of ferroptosis". Cellular and Molecular Life Sciences. 73 (11–12): 2195–2209. doi:10.1007/s00018-016-2194-1. PMC 4887533. PMID 27048822.
Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, et al. (2013-02-10). "The Cystine/Glutamate Antiporter System x c − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities". Antioxidants & Redox Signaling. 18 (5): 522–555. doi:10.1089/ars.2011.4391. ISSN 1523-0864. PMC 3545354. PMID 22667998.
Bridges R, Lutgen V, Lobner D, Baker DA (July 2012). "Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling". Pharmacological Reviews. 64 (3): 780–802. doi:10.1124/pr.110.003889. PMC 3400835. PMID 22759795.
Bading H (March 2017). "Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations". The Journal of Experimental Medicine. 214 (3): 569–578. doi:10.1084/jem.20161673. PMC 5339681. PMID 28209726.
Jyotsana N, Ta KT, DelGiorno KE (23 February 2022). "The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer". Frontiers in Oncology. 12: 858462. doi:10.3389/fonc.2022.858462. PMC 8904967. PMID 35280777.

semanticscholar.org

api.semanticscholar.org

Lewerenz J, Maher P, Methner A (January 2012). "Regulation of xCT expression and system x (c) (-) function in neuronal cells". Amino Acids. 42 (1): 171–179. doi:10.1007/s00726-011-0862-x. PMID 21369940. S2CID 12056137.
Oliveira KR, Herculano AM, Crespo-López ME, do Nascimento JL (January 2010). "Pharmacological characterization of glutamate Na+-independent transport in retinal cell cultures: implications in the glutathione metabolism". Neurochemistry International. 56 (1): 59–66. doi:10.1016/j.neuint.2009.09.002. PMID 19751785. S2CID 13562289.
Hardingham GE, Fukunaga Y, Bading H (May 2002). "Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways". Nature Neuroscience. 5 (5): 405–414. doi:10.1038/nn835. PMID 11953750. S2CID 659716.

worldcat.org

search.worldcat.org

Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, et al. (2013-02-10). "The Cystine/Glutamate Antiporter System x c − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities". Antioxidants & Redox Signaling. 18 (5): 522–555. doi:10.1089/ars.2011.4391. ISSN 1523-0864. PMC 3545354. PMID 22667998.